[의약품 회수·판매중지] 에리슨제약(주) 몰시톤정4밀리그램(몰시도민)
회수 사유: 안정성시험(장기)결과 NMOR(N-니트로소몰포린) 초과검출에 따라 사전 예방적 조치로 영업자 회수 · 자진 회수 · 회수명령일자 2023-12-20 · 승인일자 2024-01-29
- Published by source
- 2023-12-20
- First seen by Reality Radar
- 2026-10-27
- Last verified
- 2026-10-27
Affected
- Manufacturer
- 에리슨제약(주)
- Products
- 몰시톤정4밀리그램(몰시도민)
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: 자진 회수: 안정성시험(장기)결과 NMOR(N-니트로소몰포린) 초과검출에 따라 사전 예방적 조치로 영업자 회수
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- 식약처 의약품 회수·판매중지 (data.go.kr) Tier A · official published 2023-12-20
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #2036 | new | 2026-10-27 | 7a9c6bb2161b…c37f50 | 4969b1db4b1d…4b85ac |
Chain head: #2110 529e5c95a190…61dba2